Replies to post #519216 on NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Meirluc

As I have pointed out in a recent post, even Dr. Stupp is on record as saying that the long term results presented by NVCR cannot be relied upon because there was no follow up. That means their 13% OS at 60 months cannot be relied upon. As you know, Dr. Stupp was a PI for the Optune trial and was an author of the clinical results in a prestigious journal. He made that statement during a presentation in, I believe, October, 2021 if memory serves.

Dr Stupp also served/serves as a consultant to NWBO and may be included as one of the 70 authors of the upcoming journal article. FWIW.

[Hopeforthefuture3]

Meirluc I'm not really a big fan of TTF/nvcr, but posters rend to write incorrect information about them and on occasion I try to bring some facts instead. They certainly did reward some of their long term investors - I purchased in the teens? Sold at 20 & 25 and they went on to over $220 and now back down in the $80s. I believed nwbo to be the better choice and move the $ into nwbo. It is just with perfect hindsight I can see that my account value would have been much better had I done the opposite. I do agree that dcvax does remarkably well for rGBM and hope we get to hear much more - was kind of hoping that here on our 2 year quiet period anniversary nwbo might just give us a gift and start giving more information
Perhaps instead we hear more detail in November by the time of the Dr Liau SNO presentation- there I kicked the can out another month. Would also be good to hear the ceo speak on the progress made and where we stand on approval applications and more...
Pedal to the metal